cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

Deficiency of Nmnat3 in mice does not decrease the NAD level in mitochondria. by Masashi Yamamoto (407190)

Inhibition of TRPC3 decreases ATP- and OAG-induced Ca²⁺ transients in striatal astrocytes. by Karin M. Streifel (653838)

“…Prior treatment with Pyr3 for 30 minutes at 37°C decreased the Ca²⁺ response to ATP, whereas only a modest additive effect was observed with Pyr3 in the presence of 10 µM MPP⁺. …”

The VPAC1 protein level is decreased in U937 cells after 48 h from miR-525-5p transfection. by Elisa Cocco (362650)

GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats - Fig 2 by Conceição S. Martins (468492)

Pertussis specific levels of B_mem decrease with time. by Inonge van Twillert (503888)

AEA and URB597 decrease cell proliferation without inducing apoptosis. by Laurie Hamtiaux (199349)

Prolonged treatment with propofol does not decrease the neural stem cell pool. by Arvind Palanisamy (3159156)

Melatonin and hypoxia/reoxygenation decrease the mitochondrial content in BeWo cells. by Lucas Sagrillo-Fagundes (6194843)

S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

“…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”

Expression of PON1 decreases superoxide levels in germ-free <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

As the number of infections <i>I</i> in a given county increases, the variance in exponential growth rate, Var(Δ<i>I</i>/<i>I</i>), decreases as . by Calvin Pozderac (10451496)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

“…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”